Trials / Terminated
TerminatedNCT03660618
LSFG-SKIN, Laser Speckle Flowgraphy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Randy Kardon · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this project is to quantify normal and abnormal skin blood flow regionally in different areas of the body(face, extremities, over burns and wounds) at baseline and over time in response to treatment or environmental changes, such as temperature, light and pressure.
Detailed description
Laser speckle skin blood flow (LSFG-SKIN) will be recorded in normal subjects and in patients with disorders affecting skin capillary perfusion, which may include cardiovascular disorders, dermatologic disorders, skin wounds, ocular disorders, psychiatric disorders, and neurologic disorders.
Conditions
- Hypertension
- Heart Failure
- Vascular Ischemia
- Burns
- Chemotherapy Effect
- Radiation Injuries
- Uveitis
- Scleritis
- Multiple Sclerosis
- Autonomic Neuropathy
- Stroke
- Intracranial Hemorrhages
- TIA
- Migraine
- Headache
- Pain
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | laser speckle flowgraphy | blood flow state of the skin as real time two dimensional image |
Timeline
- Start date
- 2017-05-23
- Primary completion
- 2019-03-02
- Completion
- 2019-03-02
- First posted
- 2018-09-06
- Last updated
- 2023-05-10
- Results posted
- 2023-05-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03660618. Inclusion in this directory is not an endorsement.